Literature DB >> 27650513

Unraveling the genomic complexity of small cell lung cancer.

Niki Karachaliou1, Aaron E Sosa2, Rafael Rosell3.   

Abstract

Entities:  

Year:  2016        PMID: 27650513      PMCID: PMC5009089          DOI: 10.21037/tlcr.2016.07.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


× No keyword cloud information.
  23 in total

1.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

2.  RET mutation and expression in small-cell lung cancer.

Authors:  Snehal Dabir; Shahab Babakoohi; Amy Kluge; James J Morrow; Adam Kresak; Michael Yang; David MacPherson; Gary Wildey; Afshin Dowlati
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

Review 3.  Molecular genetics of small cell lung carcinoma.

Authors:  I I Wistuba; A F Gazdar; J D Minna
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

4.  ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

Authors:  Jianfeng Shen; Yang Peng; Leizhen Wei; Wei Zhang; Lin Yang; Li Lan; Prabodh Kapoor; Zhenlin Ju; Qianxing Mo; Ie-Ming Shih; Ivan P Uray; Xiangwei Wu; Powel H Brown; Xuetong Shen; Gordon B Mills; Guang Peng
Journal:  Cancer Discov       Date:  2015-06-11       Impact factor: 39.397

Review 5.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

6.  Clinical correlation of extensive-stage small-cell lung cancer genomics.

Authors:  A Dowlati; M B Lipka; K McColl; S Dabir; M Behtaj; A Kresak; A Miron; M Yang; N Sharma; P Fu; G Wildey
Journal:  Ann Oncol       Date:  2016-01-22       Impact factor: 32.976

7.  High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.

Authors:  D D'Amico; D Carbone; T Mitsudomi; M Nau; J Fedorko; E Russell; B Johnson; D Buchhagen; S Bodner; R Phelps
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

Review 8.  RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.

Authors:  Paola Indovina; Francesca Pentimalli; Nadia Casini; Immacolata Vocca; Antonio Giordano
Journal:  Oncotarget       Date:  2015-07-20

9.  Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide.

Authors:  Niki Karachaliou; Chara Papadaki; Eleni Lagoudaki; Maria Trypaki; Maria Sfakianaki; Anastasios Koutsopoulos; Dimitris Mavroudis; Efstathios Stathopoulos; Vassilis Georgoulias; John Souglakos
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

10.  Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.

Authors:  Robert J Cardnell; Ying Feng; Seema Mukherjee; Lixia Diao; Pan Tong; C Allison Stewart; Fatemeh Masrorpour; YouHong Fan; Monique Nilsson; Yuqiao Shen; John V Heymach; Jing Wang; Lauren A Byers
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

View more
  8 in total

1.  Genomic alterations in small cell lung cancer and their clinical relevance.

Authors:  Gary Wildey; Afshin Dowlati
Journal:  Transl Lung Cancer Res       Date:  2016-08

2.  Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian.

Authors:  Anqi Lin; Ningning Zhou; Weiliang Zhu; Jiexia Zhang; Ting Wei; Linlang Guo; Peng Luo; Jian Zhang
Journal:  Cancer Cell Int       Date:  2022-04-29       Impact factor: 6.429

3.  Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential.

Authors:  Jing Hu; Yu Wang; Yuan Zhang; Yanfei Yu; Hui Chen; Kuai Liu; Ming Yao; Kai Wang; Weiguang Gu; Tao Shou
Journal:  Cancer Med       Date:  2019-06-14       Impact factor: 4.452

4.  Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer.

Authors:  Dongfang Chen; Jianlin Xu; Rong Qiao; Yizhuo Zhao; Tianqing Chu; Baohui Han; Runbo Zhong
Journal:  J Oncol       Date:  2020-11-19       Impact factor: 4.375

Review 5.  A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC).

Authors:  Bryan Oronsky; Nacer Abrouk; Scott Caroen; Michelle Lybeck; Xiaoning Guo; Xiaohui Wang; Zhongwen Yu; Tony Reid
Journal:  J Cancer       Date:  2022-07-18       Impact factor: 4.478

6.  Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.

Authors:  Zsolt Megyesfalvi; Nandor Barany; Andras Lantos; Zsuzsanna Valko; Orsolya Pipek; Christian Lang; Anna Schwendenwein; Felicitas Oberndorfer; Sandor Paku; Bence Ferencz; Katalin Dezso; Janos Fillinger; Zoltan Lohinai; Judit Moldvay; Gabriella Galffy; Beata Szeitz; Melinda Rezeli; Christopher Rivard; Fred R Hirsch; Luka Brcic; Helmut Popper; Izidor Kern; Mile Kovacevic; Jozef Skarda; Marcel Mittak; Gyorgy Marko-Varga; Krisztina Bogos; Ferenc Renyi-Vamos; Mir Alireza Hoda; Thomas Klikovits; Konrad Hoetzenecker; Karin Schelch; Viktoria Laszlo; Balazs Dome
Journal:  J Pathol       Date:  2022-05-25       Impact factor: 9.883

7.  Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.

Authors:  William H Gmeiner; Lance D Miller; Jeff W Chou; Anthony Dominijanni; Lysette Mutkus; Frank Marini; Jimmy Ruiz; Travis Dotson; Karl W Thomas; Graham Parks; Christina R Bellinger
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639

8.  Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP).

Authors:  Andrés F Cardona; Leonardo Rojas; Zyanya Lucia Zatarain-Barrón; Alejandro Ruiz-Patiño; Luisa Ricaurte; Luis Corrales; Claudio Martín; Helano Freitas; Vladmir Cláudio Cordeiro de Lima; July Rodriguez; Jenny Avila; Melissa Bravo; Pilar Archila; Hernán Carranza; Carlos Vargas; Jorge Otero; Feliciano Barrón; Niki Karachaliou; Rafael Rosell; Oscar Arrieta
Journal:  Front Oncol       Date:  2019-04-17       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.